Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 12-month […]
Dr Huda Zoghbi named 2023 Watanabe Prize winner miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Promising drug duo that may improve spinal muscular atrophy treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald restated their overweight rating on shares of Stoke Therapeutics (NASDAQ:STOK – Get Rating) in a report released on Friday, Zacks.com reports. Several other analysts also recently commented on the company. Jefferies Financial Group began coverage on Stoke Therapeutics in a research note on Monday, January 31st. They set a buy rating and a […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) has earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among […]